13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q3 2023. See the latest, Q2 2026 →
Reported value
$24.64B
+0.9% on the quarter before
Positions
80
15 new · 21 sold out
Top 10
42.5%
of the value
Est. gain
−$417.0M
on stocks held all quarter
Est. return
−2.3%
on those stocks since Q2 2023
Positions as of Sep 30, 2023, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2023. Striped tiles are options.
Largest buys
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- United Parcel Service Inc~$899.6MAdded · 0.7% → 4.2%+5,771,294 shares
- Microsoft~$575.4MAdded · 1.7% → 3.9%+1,822,348 shares
- Amazon~$552.8MAdded · 2.3% → 4.5%+4,348,680 shares
- Block~$545.5MNew · 0.0% → 2.2%+12,324,808 shares
- Workday~$472.2MAdded · 2.8% → 4.6%+2,198,025 shares
- Ppg Inds Inc~$408.1MAdded · 0.5% → 2.1%+3,144,226 shares
- Mckesson Corp~$406.0MAdded · 0.9% → 2.6%+933,582 shares
- Freeport-McMoRan~$364.3MNew · 0.0% → 1.5%+9,769,679 shares
- DoorDash~$212.0MAdded · 0.8% → 1.7%+2,667,172 shares
- Ameriprise Finl Inc~$201.1MAdded · 1.5% → 2.3%+609,915 shares
Largest sells
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Elevance Health Inc~$627.6MSold out · 2.6% → 0.0%−1,412,701 shares
- Sherwin Williams Co~$604.0MSold out · 2.5% → 0.0%−2,274,718 shares
- Intuit~$482.6MSold out · 2.0% → 0.0%−1,053,352 shares
- Arista Networks~$330.0MSold out · 1.4% → 0.0%−2,036,587 shares
- Philip Morris Intl Inc~$285.5MCut · 3.6% → 2.2%−3,083,708 shares
- Mastercard~$285.2MCut · 1.6% → 0.5%−720,437 shares
- Micron~$279.2MSold out · 1.1% → 0.0%−4,424,339 shares
- Netflix~$277.9MSold out · 1.1% → 0.0%−630,865 shares
- Seagate Technology Hldngs Pl~$197.1MSold out · 0.8% → 0.0%−3,186,400 shares
- Chubb Limited~$187.0MSold out · 0.8% → 0.0%−970,942 shares
Holdings
As of Sep 30, 2023. Changes are in shares against Jun 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visa Inc.COM CL A · shares −2.4% · price −3.1% | 6.5% | $1.60B | −$52.1M | ||||||||
| WorkdayCL A · shares +72% · price −4.9% | 4.6% | $1.13B | −$33.5M | ||||||||
| AmazonCOM · shares +99% · price −2.5% | 4.5% | $1.11B | −$14.3M | ||||||||
| United Parcel Service IncCL B · shares +649% · price −13.0% | 4.2% | $1.04B | −$20.8M | ||||||||
| Danaher CorporationCOM · shares −3.4% · price +3.4% | 4.1% | $1.02B | +$33.3M | ||||||||
| MicrosoftCOM · shares +152% · price −7.3% | 3.9% | $955.0M | −$29.8M | ||||||||
| Unitedhealth Group IncCOM · shares +3.5% · price +4.9% | 3.8% | $936.8M | +$42.3M | ||||||||
| MetaCL A · shares +18% · price +4.6% | 3.7% | $917.7M | +$34.3M | ||||||||
| Api Group CorpCOM STK · shares 0% · price −4.9% | 3.6% | $886.8M | −$45.5M | ||||||||
| General Electric CoCOM NEW · shares +12% · price +0.6% | 3.6% | $884.1M | +$5.0M | ||||||||
| Roivant Sciences LtdSHS · shares −2.4% · price +15.9% | 3.5% | $857.7M | +$117.5M | ||||||||
| Bridgebio Pharma IncCOM · shares −5.6% · price +53.3% | 2.7% | $662.4M | +$230.4M | ||||||||
| Mckesson CorpCOM · shares +178% · price +1.8% | 2.6% | $633.9M | +$4.0M | ||||||||
| Fortive CorpCOM · shares −15% · price −0.8% | 2.5% | $617.4M | −$5.1M | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares +8.6% · price −15.3% | 2.4% | $596.9M | −$99.5M | ||||||||
| Ameriprise Finl IncCOM · shares +54% · price −0.7% | 2.3% | $571.7M | −$2.8M | ||||||||
| Philip Morris Intl IncCOM · shares −34% · price −5.2% | 2.2% | $552.9M | −$30.1M | ||||||||
| BlockCL A · shares New | 2.2% | $545.5M | — | ||||||||
| Ppg Inds IncCOM · shares +349% · price −12.5% | 2.1% | $524.9M | −$16.7M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +8.0% · price −3.0% | 1.8% | $455.4M | −$13.0M | ||||||||
| DoorDashCL A · shares +99% · price +4.0% | 1.7% | $426.6M | +$8.2M | ||||||||
| FortinetCOM · shares −8.3% · price −22.4% | 1.7% | $413.7M | −$119.2M | ||||||||
| CadenceCOM · shares −5.5% · price −0.1% | 1.6% | $387.4M | −$363,710 | ||||||||
| Biomarin Pharmaceutical IncCOM · shares +1.4% · price +2.1% | 1.5% | $373.0M | +$7.5M | ||||||||
| Freeport-McMoRanCL B · shares New | 1.5% | $364.3M | — | ||||||||
| Total · 80 positions | 100% | $24.64B | −$417.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2023 to Q3 2023: 64 stocks held throughout, down $417.0M (−2.3%).
- Bridgebio Pharma Inc+$230.4M+53%
- Roivant Sciences Ltd+$117.5M+16%
- Unitedhealth Group Inc+$42.3M+5%
- Meta+$34.3M+5%
- Danaher Corporation+$33.3M+3%
- Api Group Corp−$45.5M−5%
- Inhibrx Inc−$50.5M−29%
- Visa Inc.−$52.1M−3%
- Hdfc Bank Ltd−$99.5M−15%
- Fortinet−$119.2M−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |